Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1454 ARTÍCULOS , VIENDO DEL 781 AL 795

Advances in longitudinal studies of amnestic mild cognitive impairment and Alzheimer's disease based on multi-modal MRI techniques

Hu Z, Wu L, Jia J, Han Y.

Neurosci Bull. 2014 Apr;30(2):198-206. doi: 10.1007/s12264-013-1407-y. Epub 2014 Feb 27.

Fractional anisotropy changes in Alzheimer's disease depend on the underlying fiber tract architecture: a multiparametric DTI study using joint independent component analysis

Teipel SJ, Grothe MJ, Filippi M, Fellgiebel A, Dyrba M, Frisoni GB, Meindl T, Bokde AL, Hampel H, Klöppel S, Hauenstein K; EDSD study group.

J Alzheimers Dis. 2014;41(1):69-83. doi: 10.3233/JAD-131829.

Systematic review of the risk of dementia and chronic cognitive impairment after mild traumatic brain injury: results of the International Collaboration on Mild Traumatic Brain Injury Prognosis

Godbolt AK, Cancelliere C, Hincapié CA, Marras C, Boyle E, Kristman VL, Coronado VG, Cassidy JD.

Arch Phys Med Rehabil. 2014 Mar;95(3 Suppl):S245-56. doi: 10.1016/j.apmr.2013.06.036.

Cognitive and affective changes in mild to moderate Alzheimer's disease patients undergoing switch of cholinesterase inhibitors: a 6-month observational study

Spalletta G, Caltagirone C, Padovani A, Sorbi S, Attar M, Colombo D, Cravello L; E V O L U T I O N study Working Group.

PLoS One. 2014 Feb 19;9(2):e89216. doi: 10.1371/journal.pone.0089216. eCollection 2014.

Blood viscosity in subcortical vascular mild cognitive impairment with versus without cerebral amyloid burden

Noh HJ, Seo SW, Jeong Y, Park JE, Kim GH, Noh Y, Cho H, Kim HJ, Yoon CW, Ye BS, Werring DJ, Na DL.

J Stroke Cerebrovasc Dis. 2014 May-Jun;23(5):958-66. doi: 10.1016/j.jstrokecerebrovasdis.2013.08.004. Epub 2014 Feb 28.

Cerebral blood flow reduction associated with orientation for time in amnesic mild cognitive impairment and Alzheimer disease patients

Yamashita KI, Taniwaki Y, Utsunomiya H, Taniwaki T.

J Neuroimaging. 2014 Nov-Dec;24(6):590-594. doi: 10.1111/jon.12096. Epub 2014 Mar 5.

Is it time to revisit the classification guidelines for primary progressive aphasia?

Mesulam MM, Weintraub S.

Neurology. 2014 Apr 1;82(13):1108-9. doi: 10.1212/WNL.0000000000000272. Epub 2014 Mar 5.

Response to antidepressant medications in late-life depression across the spectrum of cognitive functioning

Koenig AM, Butters MA, Begley A, Ogbagaber S, Wahed AS, Reynolds CF 3rd.

J Clin Psychiatry. 2014 Feb;75(2):e100-7. doi: 10.4088/JCP.13m08442.

Amyloid imaging in depression: a predictor of Alzheimer's disease?

Camacho V, Lleó A.

Eur J Nucl Med Mol Imaging. 2014 Apr;41(4):711-3. doi: 10.1007/s00259-014-2741-7.

Effects of Multisensory Stimulation on a Sample of Institutionalized Elderly People With Dementia Diagnosis: A Controlled Longitudinal Trial

Maseda A, Sánchez A, Marante MP, González-Abraldes I, Buján A, Millán-Calenti JC.

Am J Alzheimers Dis Other Demen. 2014 Aug;29(5):463-73. doi: 10.1177/1533317514522540. Epub 2014 Mar 6.

Risk factors for incident delirium among older people in acute hospital medical units: a systematic review and meta-analysis

Ahmed S, Leurent B, Sampson EL.

Age Ageing. 2014 May;43(3):326-33. doi: 10.1093/ageing/afu022. Epub 2014 Mar 6.

Pittsburgh compound B retention and progression of cognitive status--a meta-analysis

Chen X, Li M, Wang S, Zhu H, Xiong Y, Liu X.

Eur J Neurol. 2014 Aug;21(8):1060-1067. doi: 10.1111/ene.12398. Epub 2014 Feb 24.

The Chinese version of story recall: a useful screening tool for mild cognitive impairment and Alzheimer's disease in the elderly

Shi J, Wei M, Tian J, Snowden J, Zhang X, Ni J, Li T, Jian W, Ma C, Tong Y, Liu J, Liu T, Wang P, Wang Y.

BMC Psychiatry. 2014 Mar 10;14:71. doi: 10.1186/1471-244X-14-71.

Neuropsychiatric symptoms in the prodromal stages of dementia

Stella F, Radanovic M, Balthazar ML, Canineu PR, de Souza LC, Forlenza OV.

Curr Opin Psychiatry. 2014 May;27(3):230-5. doi: 10.1097/YCO.0000000000000050.

Florbetapir F 18 amyloid PET and 36-month cognitive decline: a prospective multicenter study

Doraiswamy PM, Sperling RA, Johnson K, Reiman EM, Wong TZ, Sabbagh MN, Sadowsky CH, Fleisher AS, Carpenter A, Joshi AD, Lu M, Grundman M, Mintun MA, Skovronsky DM, Pontecorvo MJ; AV45-A11 Study Group; AV45-A11 Study Group.

Mol Psychiatry. 2014 Sep;19(9):1044-51. doi: 10.1038/mp.2014.9. Epub 2014 Mar 11.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias